4-farnesyl-5-methylresorcinol

has antimicrobial, antioxidant, and cytotoxic activities; also inhibits tyrosinase; isolated from Albatrellus confluens and Polyporus confluens

Also Known As:

4-trans,trans-farnesyl-5-methylresorcinol; neogrifolin

Networked: 2 relevant articles (0 outcomes, 1 trials/studies)

1.	Egger, Keith N: 1 article (01/2020)
2.	Lee, Chow H: 1 article (01/2020)
3.	Li, Wai Ming: 1 article (01/2020)
4.	Liu, Victor: 1 article (01/2020)
5.	Mackedenski, Sebastian: 1 article (01/2020)
6.	Massicotte, Hugues B: 1 article (01/2020)
7.	Reimer, Kerry: 1 article (01/2020)
8.	Tackaberry, Linda E: 1 article (01/2020)
9.	Wang, Chuyi: 1 article (01/2020)
10.	Yaqoob, Almas: 1 article (01/2020)

1.	Osteosarcoma (Osteogenic Sarcoma) 01/01/2015 - "Hence, in this study, we investigated the apoptosis-inducing effects and the mechanisms of neogrifolin on human osteosarcoma cells. " 01/01/2015 - "Collectively, our results suggested that neogrifolin is a potential candidate for osteosarcoma. " 01/01/2015 - "On the other hand, neogrifolin treatment also down-regulated the expression of the inhibitor of apoptosis protein (IAP) in both osteosarcoma cells. "
2.	Colonic Neoplasms (Colon Cancer) 01/01/2020 - "Grifolin, neogrifolin and confluentin from the terricolous polypore Albatrellus flettii suppress KRAS expression in human colon cancer cells."

1.	Inhibitor of Apoptosis Proteins
2.	confluentin
3.	grifolin